Status:
COMPLETED
Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Avon Foundation
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-101 years
Phase:
NA
Brief Summary
Women with breast cancer often suffer significant distress and disability from their disease. A practice of meditation-based stress reduction and cognitive-affective-behavioral learning may help women...
Detailed Description
The objective of this study in women recently treated for breast cancer is to determine whether an intervention program consisting of group and individual instruction in a meditation-based practice of...
Eligibility Criteria
Inclusion
- All women with stage I-III breast cancer who have received treatment within the preceding year will be eligible for inclusion in the study.
Exclusion
- Patients who refuse to participate will be excluded
- Patients with metastatic (stage IV) cancer are excluded.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT00278837
Start Date
May 1 2003
End Date
March 1 2010
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021